And that kind of revenue could easily fund Tpm Oxy & TPM Insulin thru Phase 3 trials Without any placement external funding required . POHs personal care rollout is strategically unique among Biotechs.
What I would like to know about Cellucreme is whether customers having reduced or removed their cellulite must keep using the product to keep this condition under control? ...... That is do they become customers for life?
the positive side if elixia launch ?fails?, page-9
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(16.7%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $194 | 65.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 88502619 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 60023414 | 20 |
View Market Depth
| Last trade - 12.52pm 20/08/2024 (20 minute delay) ? |
| AVE (ASX) Chart |